Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial

F. Trillsch, Sven Mahner, F. Hilpert, L. Davies, E. García-Martínez, G. Kristensen, A. Savarese, P. Vuylsteke, M. Los, F. Zagouri, L. Gladieff, J. Sehouli, C. Khoon Lee, V. Gebski, E. Pujade-Lauraine

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial'. Together they form a unique fingerprint.

Medicine & Life Sciences